1. Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea 
Hang Wun Raymond Li, M.R.C.O.G., Richard A. Anderson, M.D., Ph.D., William Shu Biu Yeung, Ph.D., Pak Chung Ho, M.D., Ernest Hung Yu Ng, M.D. 
Fertility and Sterility 
Volume 96, Issue 3, Pages (September 2011)
DOI: /j.fertnstert
Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Box-whisker plot of (A) serum AMH concentration in different diagnostic groups of secondary amenorrhea (∗P<.01 vs. control; ∗∗P<.001 vs. control); (B) serum inhibin B concentration in different diagnostic groups of secondary amenorrhea (∗P<.001 versus control, PCOS, and HPRL); and (C) serum AMH concentration in WHO group 2 anovulatory disorder with or without fulfilling the criteria of polycystic ovary syndrome (PCOS) (∗P<.05 versus control; ∗∗P<.001 versus control, P<.01 versus non-PCOS WHO group 2 anovulation). The boxes represent the median (horizontal rule) and interquartile ranges, whiskers the full range. WHO 1, 2, and 3 = World Health Organization Group 1, 2, and 3 anovulatory disorders; PCOS = polycystic ovary syndrome; HPRL = hyperprolactinaemia. The WHO 2 (all) group incorporates WHO 2 subjects with or without fulfilling the Rotterdam criteria for PCOS.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Receiver operating characteristic (ROC) curves of serum AMH in discrimination of (A) polycystic ovary syndrome (PCOS) versus control; (B) World Health Organization group 2 anovulation (all) versus control; (C) ovarian failure versus control; and (D) PCOS versus hypogonadotropic hypogonadism.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions